Male hormone-interfering drugs and meningioma development.
Laura GiraldiJørgen Vinsløv HansenJan WohlfahrtMads MelbyeKåre FugleholmTina Nørgaard MunchPublished in: Neuro-oncology advances (2019)
As opposed to previous studies, we found no evidence of an increased risk of meningioma in men treated with male hormone-interfering drugs.
Keyphrases